OraSure Technologies Inc. was awarded a three-year contract for up to $10.4 million in funding from the U.S. Department of Health and Human Services to advance clinical development of a rapid antigen test for Ebola. Orasure’s OraQuick Ebola Rapid Antigen Test can be used in a doctor’s office, hospital, clinic or field setting and can provide results within 20 minutes. The test could be crucial in containing Ebola outbreaks. Read more: http://bit.ly/1QSFV6p http://bit.ly/1BbCh5w
Client & Alumni News
OraSure lands up to $10M contract for rapid Ebola test
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.